Group A: surgery for leiomyoma (n=9) | Group B: surgery for pelvic organ prolapse (n=6) | P-value | |
---|---|---|---|
Age at surgery | 56 (52–69) | 61 (54–66) | 0.594 |
Menopause age | 50 (50–51) | 49 (47.8–52) | 0.171 |
Years passed after menopause | 6 (2–19) | 11.5 (7–15.5) | 0.441 |
Parity | 1 (0.5–2.5) | 2 (1.75–2.25) | 0.325 |
Body mass index (BMI) | 24.0 (20.4–27.9) | 23.3 (18.1–28.1) | 0.637 |
Maximum diameter of leiomyoma (cm) | 10.5 (8.5–17.5) | 5 (1.8–5.5) | < 0.001 |
Degeneration | 9 (100%) | 4 (67%) | 0.328 |
Hyaline | 6 (67%) | 4 (67%) | 1 |
Edematous | 3 (33%)* | 0 | 0.328 |
Myxoid | 2 (22%) | 0 | 0.529 |